Jennison Associates LLC Novo Nordisk A S Transaction History

Jennison Associates LLC

$167 Billion
Q2 2025

A detailed history of Jennison Associates LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Jennison Associates LLC holds 18,885,343 shares of NVO stock, worth $940 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

18,885,343

Previous 18,822,002 0.34%

Holding current value

$940 Million

Previous $1.31 Billion 0.27%

% of portfolio

0.78%

Previous 0.93%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 01, 2025	BUY	$58.08 - $81.05 $3.68 Million - $5.13 Million	63,341 Added 0.34%	18,885,343 $1.3 Billion
Q1 2025 May 02, 2025	SELL	$69.3 - $90.95 $77.8 Million - $102 Million	-1,122,807 Reduced 5.63%	18,822,002 $1.31 Billion
Q4 2024 Jan 24, 2025	SELL	$85.0 - $120.04 $21.3 Million - $30.1 Million	-251,148 Reduced 1.24%	19,944,809 $1.72 Billion
Q3 2024 Nov 08, 2024	SELL	$119.07 - $145.42 $122 Million - $149 Million	-1,024,684 Reduced 4.83%	20,195,957 $2.4 Billion
Q2 2024 Aug 05, 2024	BUY	$122.71 - $146.91 $16.7 Million - $20 Million	136,027 Added 0.65%	21,220,641 $3.03 Billion
Q1 2024 May 02, 2024	SELL	$102.11 - $135.92 $147 Million - $196 Million	-1,443,158 Reduced 6.41%	21,084,614 $2.71 Billion
Q4 2023 Feb 01, 2024	SELL	$87.78 - $105.45 $78.3 Million - $94 Million	-891,633 Reduced 3.81%	22,527,772 $2.33 Billion
Q3 2023 Oct 31, 2023	BUY	$90.94 - $199.54 $1.07 Billion - $2.34 Billion	11,727,507 Added 100.3%	23,419,405 $2.13 Billion
Q2 2023 Aug 03, 2023	SELL	$155.98 - $172.65 $101 Million - $112 Million	-649,563 Reduced 5.26%	11,691,898 $1.89 Billion
Q1 2023 Apr 26, 2023	BUY	$132.34 - $159.14 $117 Million - $141 Million	886,679 Added 7.74%	12,341,461 $1.96 Billion
Q4 2022 Feb 09, 2023	BUY	$102.55 - $135.33 $53.8 Million - $71 Million	524,276 Added 4.8%	11,454,782 $1.55 Billion
Q3 2022 Nov 01, 2022	BUY	$95.28 - $116.93 $39.4 Million - $48.3 Million	413,285 Added 3.93%	10,930,506 $1.09 Billion
Q2 2022 Aug 02, 2022	BUY	$103.24 - $121.81 $515 Million - $608 Million	4,989,744 Added 90.27%	10,517,221 $1.17 Billion
Q1 2022 May 11, 2022	BUY	$93.1 - $112.54 $453 Million - $547 Million	4,862,299 Added 730.98%	5,527,477 $614 Million
Q4 2021 Feb 08, 2022	BUY	$95.88 - $117.08 $17 Million - $20.7 Million	176,997 Added 36.26%	665,178 $74.5 Million
Q3 2021 Nov 09, 2021	BUY	$84.42 - $106.62 $10,299 - $13,007	122 Added 0.02%	488,181 $46.9 Million
Q2 2021 Aug 12, 2021	SELL	$67.66 - $84.76 $8,254 - $10,340	-122 Reduced 0.02%	488,059 $40.9 Million
Q1 2021 May 11, 2021	SELL	$67.06 - $75.82 $12 Million - $13.6 Million	-179,584 Reduced 26.89%	488,181 $32.9 Million
Q4 2020 Feb 05, 2021	SELL	$63.89 - $73.8 $21.8 Million - $25.1 Million	-340,595 Reduced 33.78%	667,765 $46.6 Million
Q3 2020 Nov 04, 2020	BUY	$63.69 - $70.22 $861,725 - $950,076	13,530 Added 1.36%	1,008,360 $70 Million
Q2 2020 Aug 06, 2020	SELL	$58.54 - $67.94 $9.24 Million - $10.7 Million	-157,780 Reduced 13.69%	994,830 $65.1 Million
Q1 2020 May 06, 2020	BUY	$49.46 - $64.78 $1 Million - $1.31 Million	20,276 Added 1.79%	1,152,610 $69.4 Million
Q4 2019 Feb 07, 2020	BUY	$49.86 - $58.26 $543,025 - $634,509	10,891 Added 0.97%	1,132,334 $65.5 Million
Q3 2019 Nov 08, 2019	SELL	$47.54 - $53.43 $5.16 Million - $5.8 Million	-108,543 Reduced 8.82%	1,121,443 $58 Million
Q2 2019 Aug 06, 2019	BUY	$46.79 - $52.47 $27.2 Million - $30.5 Million	580,944 Added 89.51%	1,229,986 $0
Q1 2019 May 10, 2019	BUY	$46.36 - $52.63 $30.1 Million - $34.2 Million	649,042 New	649,042 $34 Million

Others Institutions Holding NVO

# of Institutions

1,742

Shares Held

321M

Call Options Held

13.7M

Put Options Held

19.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $112B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account

Jennison Associates LLC Novo Nordisk A S Transaction History